UniProtKB/Swiss-Prot P01130: Variant p.Val806Asp

Low-density lipoprotein receptor
Gene: LDLR
Feedback?

Variant information Variant position:

806 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Aspartate (D) at position 806 (V806D, p.Val806Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (V) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In FHCL1; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs879255208 [ dbSNP | Ensembl ]

Sequence information Variant position:

806 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

860 The length of the canonical sequence.
Location on the sequence:

SVRALSIVLPIVLLVFLCLG V FLLWKNWRLKNINSINFDNP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SVRALSIVLPIVLLVFLCLGVFLLWKNWRLKNINSINFDNP

Mouse                         GMRFLSIFFPIALVALLVLGAVLLWRNWRLKNINSINFDNP

Rat                           GVGFLSIFLPIALVALLVFGAILLWRNWRLRNINSINFDNP

Bovine                        SVGALYIVLPIALLILLAFGTFLLWKNWRLKSINSINFDNP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	22 – 860	Low-density lipoprotein receptor
Transmembrane	789 – 810	Helical
Mutagenesis	811 – 811	K -> R. No change. No change; when associated with R-816 and R-830. Insensitive to MYLIP-triggered degradation; when associated with R-816; R-830 and A-839.
Mutagenesis	816 – 816	K -> R. No change. No change; when associated with R-830. No change; when associated with R-811 and R-830. Insensitive to MYLIP-triggered degradation; when associated with R-830 and A-839. Insensitive to MYLIP-triggered degradation; when associated with R-811; R-830 and A-839.
Mutagenesis	821 – 821	I -> A. 3-fold decreased affinity for LDLRAP1.
Mutagenesis	821 – 821	I -> R. 10-fold decreased affinity for LDLRAP1.

Literature citations
Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia.
Nauck M.S.; Koester W.; Doerfer K.; Eckes J.; Scharnagl H.; Gierens H.; Nissen H.; Nauck M.A.; Wieland H.; Maerz W.;
Hum. Mutat. 18:165-166(2001)
Cited for: INVOLVEMENT IN FHCL1; VARIANTS FHCL1 ARG-143; TYR-148; TRP-184; CYS-574; ASP-639 AND ASP-806; VARIANTS TRP-257 AND ILE-742;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.